全球活細胞成像市場研究報告 - 2024 年至 2032 年產業分析、規模、佔有率、成長、趨勢和預測

全球活細胞成像市場需求預計將從2023年的29.4億美元達到近73.5億美元的市場規模，2024-2032年研究期間複合年成長率為10.73%。

活細胞成像是一種能夠快速、長期觀察體內細胞的顯微鏡方法。適用於活細胞成像的顯微鏡技術包括傳統的對比技術，例如微分乾涉對比或相差，以及基於螢光的方法。科學家利用它來利用細胞動力學來更好地了解生物活動。它也有助於研究動態複雜分子的構造和相互作用、病毒顆粒活性以及細胞對環境訊號的反應。由於演算法和資料處理等技術的最新改進，活細胞成像可以監測動物體內的分子。活細胞影像技術在醫學領域越來越受歡迎。

市場動態

在預測期內，活細胞成像市場的重要性預計將成長。傳染病和慢性疾病的日益普及增加了有效研究和開發的必要性，以便更好地了解細胞過程來解決醫學疾病。研究人員和科學家對細胞研究的興趣日益濃厚，推動了創新成像技術的採用，從而增加了對活細胞成像市場的需求。此外，推動這項技術需求成長的關鍵原因之一是人們對癌症的日益擔憂，因此政府正在積極資助以細胞為基礎的研究。為了發現新藥，製藥公司擴大在研發中使用活細胞成像，從而推動市場成長。然而，合格專業人員的稀缺和高內容篩選設備的高成本可能會在整個預測時間內抑制市場擴張。

研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。此外，這些工具也對全球活細胞成像市場的各個細分市場進行了包容性評估。活細胞成像產業的成長和趨勢為本研究提供了整體方法。

市場區隔

活細胞成像市場報告的這一部分提供了國家和地區層面細分市場的詳細資料，從而幫助策略家確定相應產品或服務的目標人群以及即將到來的機會。

按產品和服務

• 儀器（顯微鏡、獨立系統、細胞分析儀、配件）
• 耗材（試劑、檢測試劑盒、培養基、其他耗材）
• 軟體
• 服務

按申請

• 細胞生物學
• 幹細胞
• 發育生物學
• 藥物發現

依技術

• 延時顯微鏡
• 螢光共振能量轉移 (FRET)
• 光漂白後的螢光恢復 (FRAP)
• 高內涵篩選（HCS）
• 其他技術

按最終用戶

• 製藥與生物技術公司
• 學術及研究機構
• 合約研究組織

區域分析

本節涵蓋區域前景，重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲活細胞成像市場當前和未來的需求。此外，該報告重點關注所有主要地區各個應用領域的需求、估計和預測。

該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。活細胞影像市場的主要參與者包括丹納赫（美國）、蔡司集團（德國）、尼康公司（日本）、奧林巴斯公司（日本）、珀金埃爾默公司（美國）、賽多利斯公司（德國）、安捷倫科技公司。 （美國）、Becton、Dickinson 和Company (BD)（美國）、Merck KGaA（德國）、Bio-Rad Laboratories Inc.（美國）。本節包含競爭格局的整體視圖，包括各種策略發展，例如關鍵併購、未來產能、合作夥伴關係、財務概況、合作、新產品開發、新產品發布和其他發展。

如果您有任何客製化要求，請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。

目錄

第1章：前言

• 報告說明
  • 客觀的
  • 目標受眾
  • 獨特的銷售主張 (USP) 和產品
• 研究範圍
• 研究方法
  • 市場研究過程
  • 市場研究方法論

第 2 章：執行摘要

• 市場亮點
• 全球市場概況

第 3 章：活細胞影像學 - 產業分析

• 簡介 - 市場動態
• 市場促進因素
• 市場限制
• 機會
• 產業動態
• 波特五力分析
• 市場吸引力分析
  • 按產品和服務分類的市場吸引力分析
  • 市場吸引力分析：依應用分類
  • 按技術分類的市場吸引力分析
  • 最終用戶的市場吸引力分析
  • 市場吸引力分析：按地區

第 4 章：價值鏈分析

• 價值鏈分析
• 原料分析
  • 原料清單
  • 原料廠商清單
  • 主要原物料價格走勢
• 潛在買家名單
• 行銷管道
  • 直效行銷
  • 間接行銷
  • 行銷通路發展趨勢

第 5 章：全球活細胞影像市場分析：按產品和服務分類

• 按產品和服務概述
• 按產品和服務進行歷史和預測資料分析
• 儀器（顯微鏡、獨立系統、細胞分析儀、配件）
• 耗材（試劑、檢測試劑盒、培養基、其他耗材）
• 軟體
• 服務

第 6 章：全球活細胞影像市場分析：依應用分類

• 概述：按應用
• 歷史與預測資料分析：按應用分類
• 細胞生物學
• 幹細胞
• 發育生物學
• 藥物發現

第 7 章：全球活細胞影像市場分析：依技術分類

• 依技術概述
• 按技術進行歷史和預測數據分析
• 延時顯微鏡
• 螢光共振能量轉移 (FRET)
• 光漂白後的螢光恢復 (FRAP)
• 高內涵篩選（HCS）
• 其他技術

第 8 章：全球活細胞影像市場分析：依最終使用者分類

• 最終用戶概述
• 最終用戶的歷史和預測數據分析
• 製藥與生物技術公司
• 學術及研究機構
• 合約研究組織

第 9 章：全球活細胞影像市場分析：按地理位置

• 區域展望
• 介紹
• 北美銷售分析
  • 概覽、歷史與預測資料銷售分析
  • 北美按細分市場銷售分析
  • 北美按國家銷售分析
  • 美國銷售分析
  • 加拿大銷售分析
  • 墨西哥銷售分析
• 歐洲銷售分析
  • 概覽、歷史與預測資料銷售分析
  • 歐洲按細分市場銷售分析
  • 歐洲按國家銷售分析
  • 英國銷售分析
  • 法國銷售分析
  • 德國銷售分析
  • 義大利銷售分析
  • 俄羅斯銷售分析
  • 歐洲其他地區銷售分析
• 亞太地區銷售分析
  • 概覽、歷史與預測資料銷售分析
  • 亞太地區按細分市場銷售分析
  • 亞太地區按國家銷售分析
  • 中國銷售分析
  • 印度銷售分析
  • 日本銷售分析
  • 韓國銷售分析
  • 澳洲銷售分析
  • 東南亞銷售分析
  • 亞太地區其他地區銷售分析
• 拉丁美洲銷售分析
  • 概覽、歷史與預測資料銷售分析
  • 拉丁美洲按細分市場銷售分析
  • 拉丁美洲按國家銷售分析
  • 巴西銷售分析
  • 阿根廷銷售分析
  • 秘魯銷售分析
  • 智利銷售分析
  • 拉丁美洲其他地區銷售分析
• 中東和非洲銷售分析
  • 概覽、歷史與預測資料銷售分析
  • 中東和非洲按細分市場銷售分析
  • 中東和非洲按國家銷售分析
  • 沙烏地阿拉伯銷售分析
  • 阿拉伯聯合大公國銷售分析
  • 以色列銷售分析
  • 南非銷售分析
  • 中東其他地區和非洲銷售分析

第 10 章：活細胞成像公司的競爭格局

• 活細胞成像市場競爭
• 夥伴關係/協作/協議
• 併購
• 新產品發布
• 其他發展

第 11 章：公司簡介

• 頂級公司市佔率分析
• 市場集中度
• Danaher (US)
• 公司概況
• 公司收入
• 產品
• 最新動態
• ZEISS Group (Germany)
• 公司概況
• 公司收入
• 產品
• 最新動態
• Nikon Corporation (Japan)
• 公司概況
• 公司收入
• 產品
• 最新動態
• Olympus Corporation (Japan)
• 公司概況
• 公司收入
• 產品
• 最新動態
• PerkinElmer Inc. (US)
• 公司概況
• 公司收入
• 產品
• 最新動態
• Sartorius AG (Germany)
• 公司概況
• 公司收入
• 產品
• 最新動態
• Agilent Technologies Inc. (US)
• 公司概況
• 公司收入
• 產品
• 最新動態
• Thermo Fisher Scientific Inc. (US)
• 公司概況
• 公司收入
• 產品
• 最新動態
• Etaluma Inc. (US)
• 公司概況
• 公司收入
• 產品
• 最新動態
• Cytosmart Technologies (Netherlands)
• 公司概況
• 公司收入
• 產品
• 最新動態
• NanoEnTek Inc. (South Korea)
• 公司概況
• 公司收入
• 產品
• 最新動態
• GE Healthcare (US)
• 公司概況
• 公司收入
• 產品
• 最新動態
• Bruker Corporation (US)
• 公司概況
• 公司收入
• 產品
• 最新動態
• Becton
• 公司概況
• 公司收入
• 產品
• 最新動態
• Dickinson And Company (BD) (US)
• 公司概況
• 公司收入
• 產品
• 最新動態
• Merck KGaA (Germany)
• 公司概況
• 公司收入
• 產品
• 最新動態
• Bio-Rad Laboratories Inc. (US)
• 公司概況
• 公司收入
• 產品
• 最新動態

註 - 在公司概況中，財務詳細資訊和最新發展視情況而定，或對私人公司而言可能不包括在內

The global demand for Live Cell Imaging Market is presumed to reach the market size of nearly USD 7.35 Billion by 2032 from USD 2.94 Billion in 2023 with a CAGR of 10.73% under the study period 2024-2032.

Live-cell imaging is a microscopy method that enables rapid and long-term observation of cells in vivo. Microscopy techniques suitable for live-cell imaging include traditional contrast techniques, such as differential interference contrast or phase contrast, and fluorescence-based approaches. Scientists use it to understand biological activities better using cellular dynamics. It also aids in studying dynamic complex molecule construction and interaction, viral particle activity, and cellular responses to environmental signals. Live-cell imaging can monitor molecules within animals because of recent improvements in technology such as algorithms and data processing. The live-cell imaging technology is gaining popularity in the medical field.

MARKET DYNAMICS

Over the projected period, the live cell imaging market is predicted to grow in importance. The growing prevalence of infectious and chronic illnesses increases the necessity for effective research and development to understand better cell processes to tackle medical disorders. The increasing interest among researchers and scientists in cell-based research is driving the adoption of innovative imaging technologies, boosting demand for the live-cell imaging market. In addition, one of the critical causes driving the rise in demand for this technology is the growing worry about cancer, so the government is aggressively funding cell-based research. For uncovering new medicines, pharmaceutical companies are increasingly using live cell imaging in their research and development, thereby propelling market growth. However, the scarcity of qualified professionals and the high cost of high-content screening devices may stifle market expansion throughout the forecast timeline.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Live Cell Imaging. The growth and trends of Live Cell Imaging industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Live Cell Imaging market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product & Service

• Instruments (Microscopes Standalone Systems Cell Analysers Accessories)
• Consumables (Reagents Assay Kits Media Other Consumables)
• Software
• Services

By Application

• Cell Biology
• Stem Cells
• Developmental Biology
• Drug Discovery

By Technology

• Time-Lapse Microscopy
• Fluorescence Resonance Energy Transfer (FRET)
• Fluorescence Recovery After Photobleaching (FRAP)
• High Content Screening (HCS)
• Other Technologies

By End User

• Pharmaceutical & Biotechnology Companies
• Academic and Research Institutes
• Contract Research Organisations

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Live Cell Imaging market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Live Cell Imaging market include Danaher (US), ZEISS Group (Germany), Nikon Corporation (Japan), Olympus Corporation (Japan), PerkinElmer Inc. (US), Sartorius AG (Germany), Agilent Technologies Inc. (US), Thermo Fisher Scientific Inc. (US), Etaluma Inc. (US), Cytosmart Technologies (Netherlands), NanoEnTek Inc. (South Korea), GE Healthcare (US), Bruker Corporation (US), Becton, Dickinson And Company (BD) (US), Merck KGaA (Germany), Bio-Rad Laboratories Inc. (US). This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1. PREFACE

• 1.1. Report Description
  • 1.1.1 Objective
  • 1.1.2 Target Audience
  • 1.1.3 Unique Selling Proposition (USP) & offerings
• 1.2. Research Scope
• 1.3. Research Methodology
  • 1.3.1 Market Research Process
  • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

• 2.1. Highlights of Market
• 2.2. Global Market Snapshot

3. LIVE CELL IMAGING - INDUSTRY ANALYSIS

• 3.1. Introduction - Market Dynamics
• 3.2. Market Drivers
• 3.3. Market Restraints
• 3.4. Opportunities
• 3.5. Industry Trends
• 3.6. Porter's Five Force Analysis
• 3.7. Market Attractiveness Analysis
  • 3.7.1 Market Attractiveness Analysis By Product & Service
  • 3.7.2 Market Attractiveness Analysis By Application
  • 3.7.3 Market Attractiveness Analysis By Technology
  • 3.7.4 Market Attractiveness Analysis By End User
  • 3.7.5 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

• 4.1. Value Chain Analysis
• 4.2. Raw Material Analysis
  • 4.2.1 List of Raw Materials
  • 4.2.2 Raw Material Manufactures List
  • 4.2.3 Price Trend of Key Raw Materials
• 4.3. List of Potential Buyers
• 4.4. Marketing Channel
  • 4.4.1 Direct Marketing
  • 4.4.2 Indirect Marketing
  • 4.4.3 Marketing Channel Development Trend

5. GLOBAL LIVE CELL IMAGING MARKET ANALYSIS BY PRODUCT & SERVICE

• 5.1. Overview By Product & Service
• 5.2. Historical and Forecast Data Analysis By Product & Service
• 5.3. Instruments (Microscopes Standalone Systems Cell Analysers Accessories) Historic and Forecast Sales By Regions
• 5.4. Consumables (Reagents Assay Kits Media Other Consumables) Historic and Forecast Sales By Regions
• 5.5. Software Historic and Forecast Sales By Regions
• 5.6. Services Historic and Forecast Sales By Regions

6. GLOBAL LIVE CELL IMAGING MARKET ANALYSIS BY APPLICATION

• 6.1. Overview By Application
• 6.2. Historical and Forecast Data Analysis By Application
• 6.3. Cell Biology Historic and Forecast Sales By Regions
• 6.4. Stem Cells Historic and Forecast Sales By Regions
• 6.5. Developmental Biology Historic and Forecast Sales By Regions
• 6.6. Drug Discovery Historic and Forecast Sales By Regions

7. GLOBAL LIVE CELL IMAGING MARKET ANALYSIS BY TECHNOLOGY

• 7.1. Overview By Technology
• 7.2. Historical and Forecast Data Analysis By Technology
• 7.3. Time-Lapse Microscopy Historic and Forecast Sales By Regions
• 7.4. Fluorescence Resonance Energy Transfer (FRET) Historic and Forecast Sales By Regions
• 7.5. Fluorescence Recovery After Photobleaching (FRAP) Historic and Forecast Sales By Regions
• 7.6. High Content Screening (HCS) Historic and Forecast Sales By Regions
• 7.7. Other Technologies Historic and Forecast Sales By Regions

8. GLOBAL LIVE CELL IMAGING MARKET ANALYSIS BY END USER

• 8.1. Overview By End User
• 8.2. Historical and Forecast Data Analysis By End User
• 8.3. Pharmaceutical & Biotechnology Companies Historic and Forecast Sales By Regions
• 8.4. Academic and Research Institutes Historic and Forecast Sales By Regions
• 8.5. Contract Research Organisations Historic and Forecast Sales By Regions

9. GLOBAL LIVE CELL IMAGING MARKET ANALYSIS BY GEOGRAPHY

• 9.1. Regional Outlook
• 9.2. Introduction
• 9.3. North America Sales Analysis
  • 9.3.1 Overview, Historic and Forecast Data Sales Analysis
  • 9.3.2 North America By Segment Sales Analysis
  • 9.3.3 North America By Country Sales Analysis
  • 9.3.4 United States Sales Analysis
  • 9.3.5 Canada Sales Analysis
  • 9.3.6 Mexico Sales Analysis
• 9.4. Europe Sales Analysis
  • 9.4.1 Overview, Historic and Forecast Data Sales Analysis
  • 9.4.2 Europe By Segment Sales Analysis
  • 9.4.3 Europe By Country Sales Analysis
  • 9.4.4 United Kingdom Sales Analysis
  • 9.4.5 France Sales Analysis
  • 9.4.6 Germany Sales Analysis
  • 9.4.7 Italy Sales Analysis
  • 9.4.8 Russia Sales Analysis
  • 9.4.9 Rest Of Europe Sales Analysis
• 9.5. Asia Pacific Sales Analysis
  • 9.5.1 Overview, Historic and Forecast Data Sales Analysis
  • 9.5.2 Asia Pacific By Segment Sales Analysis
  • 9.5.3 Asia Pacific By Country Sales Analysis
  • 9.5.4 China Sales Analysis
  • 9.5.5 India Sales Analysis
  • 9.5.6 Japan Sales Analysis
  • 9.5.7 South Korea Sales Analysis
  • 9.5.8 Australia Sales Analysis
  • 9.5.9 South East Asia Sales Analysis
  • 9.5.10 Rest Of Asia Pacific Sales Analysis
• 9.6. Latin America Sales Analysis
  • 9.6.1 Overview, Historic and Forecast Data Sales Analysis
  • 9.6.2 Latin America By Segment Sales Analysis
  • 9.6.3 Latin America By Country Sales Analysis
  • 9.6.4 Brazil Sales Analysis
  • 9.6.5 Argentina Sales Analysis
  • 9.6.6 Peru Sales Analysis
  • 9.6.7 Chile Sales Analysis
  • 9.6.8 Rest of Latin America Sales Analysis
• 9.7. Middle East & Africa Sales Analysis
  • 9.7.1 Overview, Historic and Forecast Data Sales Analysis
  • 9.7.2 Middle East & Africa By Segment Sales Analysis
  • 9.7.3 Middle East & Africa By Country Sales Analysis
  • 9.7.4 Saudi Arabia Sales Analysis
  • 9.7.5 UAE Sales Analysis
  • 9.7.6 Israel Sales Analysis
  • 9.7.7 South Africa Sales Analysis
  • 9.7.8 Rest Of Middle East And Africa Sales Analysis

10. COMPETITIVE LANDSCAPE OF THE LIVE CELL IMAGING COMPANIES

• 10.1. Live Cell Imaging Market Competition
• 10.2. Partnership/Collaboration/Agreement
• 10.3. Merger And Acquisitions
• 10.4. New Product Launch
• 10.5. Other Developments

11. COMPANY PROFILES OF LIVE CELL IMAGING INDUSTRY

• 11.1. Top Companies Market Share Analysis
• 11.2. Market Concentration Rate
• 11.3. Danaher (US)
  • 11.3.1 Company Overview
  • 11.3.2 Company Revenue
  • 11.3.3 Products
  • 11.3.4 Recent Developments
• 11.4. ZEISS Group (Germany)
  • 11.4.1 Company Overview
  • 11.4.2 Company Revenue
  • 11.4.3 Products
  • 11.4.4 Recent Developments
• 11.5. Nikon Corporation (Japan)
  • 11.5.1 Company Overview
  • 11.5.2 Company Revenue
  • 11.5.3 Products
  • 11.5.4 Recent Developments
• 11.6. Olympus Corporation (Japan)
  • 11.6.1 Company Overview
  • 11.6.2 Company Revenue
  • 11.6.3 Products
  • 11.6.4 Recent Developments
• 11.7. PerkinElmer Inc. (US)
  • 11.7.1 Company Overview
  • 11.7.2 Company Revenue
  • 11.7.3 Products
  • 11.7.4 Recent Developments
• 11.8. Sartorius AG (Germany)
  • 11.8.1 Company Overview
  • 11.8.2 Company Revenue
  • 11.8.3 Products
  • 11.8.4 Recent Developments
• 11.9. Agilent Technologies Inc. (US)
  • 11.9.1 Company Overview
  • 11.9.2 Company Revenue
  • 11.9.3 Products
  • 11.9.4 Recent Developments
• 11.10. Thermo Fisher Scientific Inc. (US)
  • 11.10.1 Company Overview
  • 11.10.2 Company Revenue
  • 11.10.3 Products
  • 11.10.4 Recent Developments
• 11.11. Etaluma Inc. (US)
  • 11.11.1 Company Overview
  • 11.11.2 Company Revenue
  • 11.11.3 Products
  • 11.11.4 Recent Developments
• 11.12. Cytosmart Technologies (Netherlands)
  • 11.12.1 Company Overview
  • 11.12.2 Company Revenue
  • 11.12.3 Products
  • 11.12.4 Recent Developments
• 11.13. NanoEnTek Inc. (South Korea)
  • 11.13.1 Company Overview
  • 11.13.2 Company Revenue
  • 11.13.3 Products
  • 11.13.4 Recent Developments
• 11.14. GE Healthcare (US)
  • 11.14.1 Company Overview
  • 11.14.2 Company Revenue
  • 11.14.3 Products
  • 11.14.4 Recent Developments
• 11.15. Bruker Corporation (US)
  • 11.15.1 Company Overview
  • 11.15.2 Company Revenue
  • 11.15.3 Products
  • 11.15.4 Recent Developments
• 11.16. Becton
  • 11.16.1 Company Overview
  • 11.16.2 Company Revenue
  • 11.16.3 Products
  • 11.16.4 Recent Developments
• 11.17. Dickinson And Company (BD) (US)
  • 11.17.1 Company Overview
  • 11.17.2 Company Revenue
  • 11.17.3 Products
  • 11.17.4 Recent Developments
• 11.18. Merck KGaA (Germany)
  • 11.18.1 Company Overview
  • 11.18.2 Company Revenue
  • 11.18.3 Products
  • 11.18.4 Recent Developments
• 11.19. Bio-Rad Laboratories Inc. (US)
  • 11.19.1 Company Overview
  • 11.19.2 Company Revenue
  • 11.19.3 Products
  • 11.19.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies

LIST OF TABLES

• Market Snapshot
• Drivers: Impact Analysis
• Restraints: Impact Analysis
• List of Raw Material
• List of Raw Material Manufactures
• Analysis By Product & Service (USD MN)
• Instruments (Microscopes Standalone Systems Cell Analysers Accessories) Market Sales By Geography (USD MN)
• Consumables (Reagents Assay Kits Media Other Consumables) Market Sales By Geography (USD MN)
• Software Market Sales By Geography (USD MN)
• Services Market Sales By Geography (USD MN)
• Analysis By Application (USD MN)
• Cell Biology Market Sales By Geography (USD MN)
• Stem Cells Market Sales By Geography (USD MN)
• Developmental Biology Market Sales By Geography (USD MN)
• Drug Discovery Market Sales By Geography (USD MN)
• Analysis By Technology (USD MN)
• Time-Lapse Microscopy Market Sales By Geography (USD MN)
• Fluorescence Resonance Energy Transfer (FRET) Market Sales By Geography (USD MN)
• Fluorescence Recovery After Photobleaching (FRAP) Market Sales By Geography (USD MN)
• High Content Screening (HCS) Market Sales By Geography (USD MN)
• Other Technologies Market Sales By Geography (USD MN)
• Analysis By End User (USD MN)
• Pharmaceutical & Biotechnology Companies Market Sales By Geography (USD MN)
• Academic and Research Institutes Market Sales By Geography (USD MN)
• Contract Research Organisations Market Sales By Geography (USD MN)
• Global Live Cell Imaging Market Sales By Geography (USD MN)
• North America Market Analysis (USD MN)
• United States Market Analysis (USD MN)
• Canada Market Analysis (USD MN)
• Mexico Market Analysis (USD MN)
• Europe Market Analysis (USD MN)
• Europe Market Estimate By Country (USD MN)
• United Kingdom Market Analysis (USD MN)
• France Market Analysis (USD MN)
• Germany Market Analysis (USD MN)
• Italy Market Analysis (USD MN)
• Russia Market Analysis (USD MN)
• Spain Market Analysis (USD MN)
• Rest of Europe Market Analysis (USD MN)
• Asia Pacific Market Analysis (USD MN)
• China Market Analysis (USD MN)
• Japan Market Analysis (USD MN)
• India Market Analysis (USD MN)
• South Korea Market Analysis (USD MN)
• Australia Market Analysis (USD MN)
• South East Asia Market Analysis (USD MN)
• Rest of Asia Pacific Market Analysis (USD MN)
• Latin America Market Analysis (USD MN)
• Brazil Market Analysis (USD MN)
• Argentina Market Analysis (USD MN)
• Peru Market Analysis (USD MN)
• Chile Market Analysis (USD MN)
• Rest of Latin America Market Analysis (USD MN)
• Middle East & Africa Market Analysis (USD MN)
• Saudi Arabia Market Analysis (USD MN)
• UAE Market Analysis (USD MN)
• Israel Market Analysis (USD MN)
• South Africa Market Analysis (USD MN)
• Rest of Middle East and Africa Market Analysis (USD MN)
• Partnership/Collaboration/Agreement
• Mergers And Acquisition

LIST OF FIGURES

• Research Scope of Live Cell Imaging Report
• Market Research Process
• Market Research Methodology
• Global Live Cell Imaging Market Size, By Region (USD MN)
• Porters Five Forces Analysis
• Market Attractiveness Analysis By Product & Service
• Market Attractiveness Analysis By Application
• Market Attractiveness Analysis By Technology
• Market Attractiveness Analysis By End User
• Market Attractiveness Analysis By Region
• Value Chain Analysis
• Global Market Analysis By Product & Service (USD MN)
• Instruments (Microscopes Standalone Systems Cell Analysers Accessories) Market Sales By Geography (USD MN)
• Consumables (Reagents Assay Kits Media Other Consumables) Market Sales By Geography (USD MN)
• Software Market Sales By Geography (USD MN)
• Services Market Sales By Geography (USD MN)
• Global Market Analysis By Application (USD MN)
• Cell Biology Market Sales By Geography (USD MN)
• Stem Cells Market Sales By Geography (USD MN)
• Developmental Biology Market Sales By Geography (USD MN)
• Drug Discovery Market Sales By Geography (USD MN)
• Global Market Analysis By Technology (USD MN)
• Time-Lapse Microscopy Market Sales By Geography (USD MN)
• Fluorescence Resonance Energy Transfer (FRET) Market Sales By Geography (USD MN)
• Fluorescence Recovery After Photobleaching (FRAP) Market Sales By Geography (USD MN)
• High Content Screening (HCS) Market Sales By Geography (USD MN)
• Other Technologies Market Sales By Geography (USD MN)
• Global Market Analysis By End User (USD MN)
• Pharmaceutical & Biotechnology Companies Market Sales By Geography (USD MN)
• Academic and Research Institutes Market Sales By Geography (USD MN)
• Contract Research Organisations Market Sales By Geography (USD MN)
• Global Market Sales (USD MN)
• North America Market Sales (USD MN)
• Europe Market Sales (USD MN)
• Asia Pacific Market Sales (USD MN)
• Latin America Market Sales (USD MN)
• Middle East & Africa Market Sales (USD MN)
• Recent Development in Industry
• Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.